form15.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES
EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number 1-32608
(Exact
name of registrant as specified in charter)
8223
Roper Road NW, Edmonton, Alberta Canada T6E
6S4 780-433-4411
(Address,
including zip code, and telephone number, including area code, of registrant's
principal executive offices)
Common
Shares, no par value
(Title of
each class of securities covered by this Form)
(Titles
of all other classes of securities for which a duty to file reports under
Section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied
upon to terminate or suspend the duty to file reports:
|
Rule
12g-4(a)
(1) ý
|
Rule
12h-3(b) (1)
(ii) o
|
|
Rule
12g-4(a)
(2) o
|
Rule
15d-6 o
|
|
Rule
12h-3(b) (1)
(i) o
|
|
Approximate
number of holders of record of Common Shares as of the certification or notice
date: One
Pursuant
to the requirements of the Securities Exchange Act of 1934, ViRexx Medical Corp.
has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
|
Date:
December 23, 2008
|
VIREXX
MEDICAL CORP.
By: /s/Samira
Sakhia
Name:
Samira Sakhia
Title:
Director
|
Instruction:
This form is required by Rules 12g-4, 12h-3, and 15d-6 of the General Rules and
Regulations under the Securities Exchange Act of 1934. The registrant
shall file with the Commission three copies of Form 15, one of which shall be
manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and
title of the person signing the form shall be typed or printed under the
signature.